OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
CirculatingTP53mutations are associated with early tumor progression and poor survival in pancreatic cancer patients treated with FOLFIRINOX
Fleur van der Sijde, Zakia Azmani, Marc G. Besselink, et al.
Therapeutic Advances in Medical Oncology (2021) Vol. 13, pp. 175883592110337-175883592110337
Open Access | Times Cited: 12
Fleur van der Sijde, Zakia Azmani, Marc G. Besselink, et al.
Therapeutic Advances in Medical Oncology (2021) Vol. 13, pp. 175883592110337-175883592110337
Open Access | Times Cited: 12
Showing 12 citing articles:
Preoperative chemotherapy, radiotherapy and surgical decision-making in patients with borderline resectable and locally advanced pancreatic cancer
Thomas F. Stoop, Rutger T. Theijse, Leonard W. F. Seelen, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 21, Iss. 2, pp. 101-124
Closed Access | Times Cited: 66
Thomas F. Stoop, Rutger T. Theijse, Leonard W. F. Seelen, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 21, Iss. 2, pp. 101-124
Closed Access | Times Cited: 66
Serum CEA as a Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Non-Elevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment: A TAPS Consortium Study
Deesje Doppenberg, Thomas F. Stoop, Susan van Dieren, et al.
Annals of Surgical Oncology (2024) Vol. 31, Iss. 3, pp. 1919-1932
Closed Access | Times Cited: 9
Deesje Doppenberg, Thomas F. Stoop, Susan van Dieren, et al.
Annals of Surgical Oncology (2024) Vol. 31, Iss. 3, pp. 1919-1932
Closed Access | Times Cited: 9
Blood Sample Collection in Randomized Controlled Trials for Biomarker Discovery and Validation: Experience of the PREOPANC-2 Trial
Esther N. Dekker, Quisette P. Janssen, Jacob L. van Dam, et al.
Annals of Surgical Oncology (2025)
Open Access | Times Cited: 1
Esther N. Dekker, Quisette P. Janssen, Jacob L. van Dam, et al.
Annals of Surgical Oncology (2025)
Open Access | Times Cited: 1
High somatic mutations in circulating tumor DNA predict response of metastatic pancreatic ductal adenocarcinoma to first-line nab-paclitaxel plus S-1: prospective study
Lei Huang, Yao Lv, Shasha Guan, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Lei Huang, Yao Lv, Shasha Guan, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
A Review of Circulating Tumor DNA (ctDNA) in Pancreatic Cancer: Ready for the Clinic?
Purvi Jonnalagadda, Virginia S. Arnold, Benjamin A. Weinberg
Journal of Gastrointestinal Cancer (2025) Vol. 56, Iss. 1
Closed Access
Purvi Jonnalagadda, Virginia S. Arnold, Benjamin A. Weinberg
Journal of Gastrointestinal Cancer (2025) Vol. 56, Iss. 1
Closed Access
Evaluating Pancreatic and Biliary Neoplasms with Small Biopsy-Based Next Generation Sequencing (NGS): Doing More with Less
Ilias P. Nikas, Giannis Mountzios, Guy I. Sydney, et al.
Cancers (2022) Vol. 14, Iss. 2, pp. 397-397
Open Access | Times Cited: 13
Ilias P. Nikas, Giannis Mountzios, Guy I. Sydney, et al.
Cancers (2022) Vol. 14, Iss. 2, pp. 397-397
Open Access | Times Cited: 13
Analysis of circulating tumor DNA identifies distinct therapeutic response to intraperitoneal and intravenous paclitaxel plus S-1 in gastric cancer patients with peritoneal metastasis
Hong Yuan, Fei Xu, Shengzhou Wang, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access | Times Cited: 2
Hong Yuan, Fei Xu, Shengzhou Wang, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access | Times Cited: 2
Mutation Analysis of Pancreatic Juice and Plasma for the Detection of Pancreatic Cancer
Iris J. M. Levink, Maurice P.H.M. Jansen, Zakia Azmani, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13116-13116
Open Access | Times Cited: 6
Iris J. M. Levink, Maurice P.H.M. Jansen, Zakia Azmani, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13116-13116
Open Access | Times Cited: 6
Systematic review and meta-analysis: Diagnostic performance of DNA alterations in pancreatic juice for the detection of pancreatic cancer
Isis J. Visser, Iris J. M. Levink, Maikel P. Peppelenbosch, et al.
Pancreatology (2022) Vol. 22, Iss. 7, pp. 973-986
Open Access | Times Cited: 8
Isis J. Visser, Iris J. M. Levink, Maikel P. Peppelenbosch, et al.
Pancreatology (2022) Vol. 22, Iss. 7, pp. 973-986
Open Access | Times Cited: 8
Overexpression of CENPL mRNA potentially regulated by miR-340-3p predicts the prognosis of pancreatic cancer patients
Zhongyuan Cui, Ling Du, Jielong Wang, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Zhongyuan Cui, Ling Du, Jielong Wang, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Genetic Variations inTP53, RB1, andPTENin a Selected Sample of Slovak Patients With Metastatic Castration-resistant Prostate Cancer
KLAUDIA HÍVEŠ HOLEČKOVÁ, Márk Híveš, Marián Grendár, et al.
In Vivo (2024) Vol. 38, Iss. 6, pp. 2610-2616
Open Access
KLAUDIA HÍVEŠ HOLEČKOVÁ, Márk Híveš, Marián Grendár, et al.
In Vivo (2024) Vol. 38, Iss. 6, pp. 2610-2616
Open Access
Exploiting the molecular subtypes and genetic landscape in pancreatic cancer: the quest to find effective drugs
Nnenna Elebo, Ebtesam A. Abdel-Shafy, Stefano Cacciatore, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 1
Nnenna Elebo, Ebtesam A. Abdel-Shafy, Stefano Cacciatore, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 1
